CVS Stock Overview
CVS Health Corporation provides health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$62.79 |
| 52 Week High | US$75.52 |
| 52 Week Low | US$59.56 |
| Beta | 0.51 |
| 1 Month Change | -14.46% |
| 3 Month Change | -5.55% |
| 1 Year Change | -4.52% |
| 3 Year Change | 0.048% |
| 5 Year Change | n/a |
| Change since IPO | 182.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -3.3% | 2.7% | 0.5% |
| 1Y | -4.5% | -1.8% | 1.3% |
Return vs Industry: CVS underperformed the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: CVS underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 3.7% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months.
Volatility Over Time: CVS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | €79.63b |
| Earnings (TTM) | €7.78b |
| Revenue (TTM) | €332.44b |
10.2x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$356.62b |
| Cost of Revenue | US$303.35b |
| Gross Profit | US$53.28b |
| Other Expenses | US$44.93b |
| Earnings | US$8.34b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 6.62 |
| Gross Margin | 14.94% |
| Net Profit Margin | 2.34% |
| Debt/Equity Ratio | 78.6% |
How did CVS perform over the long term?
See historical performance and comparison